Scholar Rock Holding Corporation (SRRK): Price and Financial Metrics

Scholar Rock Holding Corporation (SRRK): $44.78

2.69 (+6.39%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

C

Add SRRK to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#187 of 334

in industry

SRRK Price/Volume Stats

Current price $44.78 52-week high $46.19
Prev. close $42.09 52-week low $6.76
Day low $41.54 Volume 2,884,100
Day high $45.84 Avg. volume 1,146,201
50-day MA $33.42 Dividend yield N/A
200-day MA $16.94 Market Cap 4.19B

SRRK Stock Price Chart Interactive Chart >


Scholar Rock Holding Corporation (SRRK) Company Bio


Scholar Rock Holding Corporation discovers and develops a class of biologic therapies that selectively target dysregulated growth factors in the disease microenvironment by modulating supracellular activation. The company’s drug discovery programs target growth factors which are present in the microenvironments of significant diseases, including fibrosis, musculoskeletal diseases, immuno-oncology, and autoimmune diseases. Its lead products include SRK-015, a selective and local inhibitor of latent myostatin activation for the treatment of primary myopathies. The company was founded in 2012 and is based in Cambridge, Massachusetts.


SRRK Latest News Stream


Event/Time News Detail
Loading, please wait...

SRRK Latest Social Stream


Loading social stream, please wait...

View Full SRRK Social Stream

SRRK Price Returns

1-mo 67.90%
3-mo 376.89%
6-mo 432.46%
1-year 138.83%
3-year 85.42%
5-year 263.18%
YTD 138.19%
2023 107.73%
2022 -63.57%
2021 -48.82%
2020 268.21%
2019 -42.62%

Continue Researching SRRK

Here are a few links from around the web to help you further your research on Scholar Rock Holding Corp's stock as an investment opportunity:

Scholar Rock Holding Corp (SRRK) Stock Price | Nasdaq
Scholar Rock Holding Corp (SRRK) Stock Quote, History and News - Yahoo Finance
Scholar Rock Holding Corp (SRRK) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!